A Study on Gastrointestinal Transit Time at the Population Level (GITTPop)

December 15, 2025 updated by: Christophe Matthys, KU Leuven

Gastrointestinal Transit Time at the Population Level: A Cross-sectional Study

The goal of this study is to investigate the baseline of gastrointestinal transit time (GITT) and explore its relationship with other health indicators in 932 healthy adult volunteers.

The main questions it aims to answer are:

What are the population-level baseline values for GITT using the blue dye method? How is GITT associated with key physiological parameters including blood metabolic markers, life style, and stool characteristics?

Participants will:

Consume a standardized blue dye muffin after overnight fasting at the research center; Offer a finger prock blood samples for metabolic profiling; Collect stool samples for moisture measurement; Complete detailed questionnaires on diet, lifestyle, and bowel habits; Record the time of first blue stool appearance to determine GITT.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

This explorative study is designed as a cross-sectional investigation aimed at establishing population-level reference values for gastrointestinal transit time (GITT). Adult participants from the general population will undergo GITT measurement using the blue-dye method. This muffin contains blue colorant that cannot be absorbed; after ingestion, it passes through the entire gastrointestinal tract and is eventually excreted in feces. Following a two-day lifestyle standardization period (including dietary and activity guidance) to minimize potential confounding effects on gastrointestinal motility, participants will attend a clinical visit where they will ingest a blue muffin. GITT will be determined by measuring both the time interval between ingestion of the blue muffin and the first appearance of blue-colored stool, and the duration from its first appearance to its complete disappearance.

The blue muffin method has been well-established in previous research for GITT assessment. Building upon the methodology developed by Berry et al., we will introduce stricter pre-test condition controls (includes dietary advice and lifestyle recommendations) and optimized the blue muffin formulation.These improvements allow for reliable measurement with a single muffin administration, which has been evaluated through KU Leuven Health Pass in a large sample size(S-70168).

To investigate potential determinants and correlates of GITT, we will collect biochemical parameters, fecal moisture, and resting metabolic rate. Additionally, participants will complete 24-h diet record and health questionnaires assessing bowel movement, physical activity habits, stress levels, sleep quality and hydration condition for subsequent correlation analyses.

Study Type

Observational

Enrollment (Estimated)

932

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers from the Flanders region who volunteered to participate in the research

Description

Inclusion Criteria:

  1. 18-65 years old
  2. 18.5 kg/m² ≤ BMI ≤ 25 kg/m² or BMI ≥ 30 kg/m² (people with normal weight or obesity)
  3. Provision of informed consent to participate.

Exclusion Criteria:

  1. Gastrointestinal conditions which may affect nutrient absorption or gastric emptying, including coeliac disease, Crohn's disease, previous resection of the small intestine other than bariatric surgery, gastroparesis;
  2. Using medications which effect gastric motility (e.g., domperidone, erythromycin, metoclopramide, prucalopride, opiates, loperamide, …)
  3. The ingredients of blue muffins include gluten, nuts, baking powder, sugar, vanilla extract and sunflower oil. Participants with allergies to these ingredients;
  4. Current diagnosis of cancer;
  5. Advanced organ failure, including chronic kidney disease Stage 5, liver cirrhosis Child-Pugh B or C, intestinal failure, heart failure stage D, or chronic obstructive pulmonary disease stage 4;
  6. Immobility;
  7. Neuromuscular degenerative conditions associated with muscular atrophy, such as myasthenia gravis, muscular dystrophies, fibromyalgia, or multiple Sclerosis;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Adult participants
Healthy adult participants without serious gastrointestinal diseases
Participants will consume a regular muffin containing blue dye

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastrointestinal transit time
Time Frame: From enrollment to the end of study at 2 weeks
Calculate the transit time by the recorded muffin consuming time, first blue stool appearance time and last blue stool appearance time
From enrollment to the end of study at 2 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Height (cm)
Time Frame: baseline
Measured using a height meter, in centimeters.
baseline
Weight (kg)
Time Frame: baseline
Measuring using a scale, in kg.
baseline
BMI
Time Frame: baseline
weight and height will be combined to report BMI in kg/m^2
baseline
Blood glucose (mmol/L)
Time Frame: baseline
Measure blood glucose by CardioChek Plus in mmol/L
baseline
Fat mass (kg)
Time Frame: baseline
Using Bodystat quadscan 4000 to measure fat mass (kg)
baseline
Lean body mass(kg)
Time Frame: baseline
Using Bodystat quadscan 4000 to measure lean body mass (kg)
baseline
Fat percentage (%)
Time Frame: baseline
Using Bodystat quadscan 4000 to measure fat%
baseline
Total cholesterol (mmol/L)
Time Frame: baseline
Measuring by Mission cholesterol Meter in mmol/L
baseline
HDL-C (mmol/L)
Time Frame: baseline
Measuring by Mission cholesterol Meter in mmol/L
baseline
LDL-C (mmol/L)
Time Frame: baseline
Measuring by Mission cholesterol Meter in mmol/L
baseline
Triglyceride (mmol/L)
Time Frame: baseline
Measuring by Mission Cholesterol Meter in mmol/L
baseline
Food record
Time Frame: 2 days after study
Participants record their 24-h diets through smartphone application
2 days after study
Stool form
Time Frame: baseline
Stool form will be evaluated by Bristol Stool Form Scale, the score is from 1 to 7, with values closer to the middle indicating more ideal stool shape.
baseline
Hydration status
Time Frame: baseline
Hydration status will be rated from 1 to 8 by Urine color chart, with higher numbers indicating that the body needs more water.
baseline
Perceived level of stress
Time Frame: baseline
The10-item Perceived Stress will be used to measures an individual's perceived level of stress over the past month. The total score ranges from 0 to 40. A higher score indicates a greater perceived level of stress.
baseline
Sleep quality
Time Frame: baseline
Pittsburgh Sleep Quality Index will be used to assess subjective sleep quality over the past month. The total score ranges from 0 to 21. A higher score indicates poorer sleep quality.
baseline
Activity level
Time Frame: baseline
The Baecke Physical Activity Questionnaire will be used to assess daily habitual physical activity, with a particular focus on work-related and exercise-related activities. It does not produce a single total score, but rather scores on three dimensions, each typically ranging from 1 to 5. On each dimension, a higher score indicates a higher level of physical activity in that area. Therefore, for assessing activity levels, a higher score is generally better.
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 1, 2025

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Study Registration Dates

First Submitted

November 17, 2025

First Submitted That Met QC Criteria

December 15, 2025

First Posted (Actual)

December 30, 2025

Study Record Updates

Last Update Posted (Actual)

December 30, 2025

Last Update Submitted That Met QC Criteria

December 15, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gastrointestinal Transit Time

Clinical Trials on Diet

Subscribe